The Veteran's service-connected residuals of chemotherapy-induced peripheral neuropathy are rated at various levels, and the Board has determined that additional development is needed to determine the current severity of his disabilities.

The deciding factor: The examination report provided inconsistent findings regarding the presence of peripheral neuropathy in the Veteran's upper and lower extremities, which requires clarification through a new VA examination.

Claimed conditions

residuals of chemotherapy-induced peripheral neuropathy, left upper extremity, residuals of chemotherapy-induced peripheral neuropathy, right upper extremity, residuals of chemotherapy-induced peripheral neuropathy, left sciatic nerve, residuals of chemotherapy-induced peripheral neuropathy, right sciatic nerve, residuals of chemotherapy-induced peripheral neuropathy, left anterior crural (femoral) nerve, residuals of chemotherapy-induced peripheral neuropathy, right anterior crural (femoral) nerve, residuals of chemotherapy-induced peripheral neuropathy, left obturator nerve, residuals of chemotherapy-induced peripheral neuropathy, right obturator nerve, residuals of chemotherapy-induced peripheral neuropathy, left external cutaneous nerve of the thigh, residuals of chemotherapy-induced peripheral neuropathy, right external cutaneous nerve of the thigh, residuals of chemotherapy-induced peripheral neuropathy, left ilio-inguinal nerve, residuals of chemotherapy-induced peripheral neuropathy, right ilio-inguinal nerve

How they argued it

Direct service connection

Exposure basis

None

Rating

Not verified here — check the original decision

Decision date

December 8, 2022

Citation

22067637

This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 22067637.